
The study authors examined data from the Health and Retirement Study, which included 2496 individuals who were at least 51 years of age.

The study authors examined data from the Health and Retirement Study, which included 2496 individuals who were at least 51 years of age.

Results of various studies show potentially promising clinical benefits associated with the use of supplementation in individuals who have the virus.

Home infusion within the larger ambulatory infusion setting poses specific advantages and disadvantages in relation to other available location options.

Technicians can help prevent drug diversion, provide care for patients with opioid use disorder.

A patient with multiple providers and health problems seeks a pharmacist’s knowledge for managing her prescribed and OTC drug products.

Avapritinib is approved for adult patients with advanced systemic mastocytosis, including individuals with aggressive systemic mastocytosis, systemic mastocytosis with an associated hematological neoplasm, and mast cell leukemia.

Updated research offers an additional 2 years of follow-up data and statistics on treatment with a combination of ibrutinib and venetoclax in patients with chronic lymphocytic leukemia.

Susan Lang, MA, MBA, the CEO of XIL Health and former senior executive with Express Grips, discusses what might happen to independent pharmacies if things continue as they are following the financial difficulties of the pandemic.

There is ample evidence to suggest that there can be considerable variability in pharmacists’ tenacity to provide comprehensive care to patients.

A lower antibody response found in one-fourth of patients taking methotrexate does not necessarily mean that these patients are not protected against COVID-19.

Common factors that contributed to increased dissatisfaction at work included workflow disruptions, role conflict, quantity of work, organizational culture, and leadership support.

The researchers found that the effect of fatigue from sleep disruption increased among patients with diabetes.

The addition of daratumumab to lenalidomide and dexamethasone resulted in a significant benefit to overall survival in patients with newly diagnosed multiple myeloma who were ineligible for autologous stem cell transplant and were treated to progression, according to the results of the phase 3 MAIA study.


A contraception toolkit helps them improve women's reproductive health.

The condition is not preventable, but there are steps that can be taken to reduce LDL-C levels in children.

In the United States, endometrial cancer is the most common cancer of female reproductive organs.

A 300 mg dose is currently available with a prescription.

The study authors said this research is the first systematic review that compares treatments for depression in those with coronary disease.

Owner Nancy Peterson enjoys taking care of patients, accompanied by popular sidekick Rosie the Rabbiter.

The "human first" health company is the first virtual specialized care company to partner with the publication.

Results from part A of a phase 3 trial showed sutimlimab caused patients to experience a rapid and sustained inhibition of C1-activated hemolysis in patients with cold agglutinin disease.

Researchers observed the structure of a lethal toxin produced by certain strains of Clostridium difficile bacteria.

New protocol for processing saliva samples with a bead mill homogenizer before real-time PCR testing has shown higher sensitivity to COVID-19 than nasopharyngeal swab testing

The study examining venetoclax and obinutuzumab is in progress and currently recruiting patients who are newly diagnosed with asymptomatic, high-risk CLL.

Dealing with a cancer diagnosis is difficult, but patients with MM have reason to be hopeful. Survival rates are on the rise, and a robust pipeline of promising immunotherapies and novel treatment options are in development.

Pharmacists have always been a vital member of the cancer care team, but the emergence of many new oral therapies is making their role in patient care a more prominent one.

The investigators created a panel of pseudotype viruses, which combined the HIV virus and SARS-CoV-2 spike protein.


The Novavax COVID-19 vaccine NVX-CoV2373 demonstrated 100% protection against moderate and severe disease and 90.4% efficacy overall in a phase 3 trial.